Daniel Baker

Insider Reports History

Entity
Individual
Location
C/O Cue Biopharma, Inc., 40 Guest Street, Boston, MA
Signature
/s/ Daniel Baker by Colin Sandercock, attorney-in-fact
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Daniel Baker:

Stock Role Class Num Shares Value Price $ Report Date Ownership
Cue Biopharma, Inc. CHIEF DEVELOPMENT OFFICER Stock Option (right to buy) 100K Mar 21, 2025 Direct
Artiva Biotherapeutics, Inc. Director Director Stock Option (Right to Buy) 27.5K Jan 28, 2025 Direct

Insider Reports Filed by Daniel Baker

Symbol Company Period Transactions Value $ Form Type Date Filed Role
CUE Cue Biopharma, Inc. Mar 21, 2025 1 $0 4 Mar 25, 2025 CHIEF DEVELOPMENT OFFICER
ARTV Artiva Biotherapeutics, Inc. Jan 28, 2025 1 $0 4 Jan 29, 2025 Director
ARTV Artiva Biotherapeutics, Inc. Jan 28, 2025 0 $0 3 Jan 29, 2025 Director
CUE Cue Biopharma, Inc. Nov 25, 2024 1 $0 4 Nov 29, 2024 CHIEF DEVELOPMENT OFFICER
CUE Cue Biopharma, Inc. Nov 25, 2024 0 $0 3 Nov 29, 2024 CHIEF DEVELOPMENT OFFICER